← Back to headlines
Analyst Optimistic on Terns Pharmaceuticals' Upcoming Leukemia Drug
An analyst expresses optimism regarding Terns Pharmaceuticals (TERN) and its upcoming leukemia drug, projecting a potential market value of $4.8 billion for the treatment.
27 Feb, 21:04 — 27 Feb, 21:04
Sources
Showing 1 of 1 sources
Related Stories
Samar Provincial Hospital Opens Free Dialysis Center in Catbalogan City
just now
Cardiologist Clarifies Creatine's Impact on Heart Health
12m ago
Slovenian Healthcare System Expected to Remain Unchanged Post-Election
15m ago
Highly Processed Foods Linked to Reduced Fertility and Slower Fetal Development
15m ago